Ability to generate patient-derived Breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes

Priscilla F. McAuliffe, Kurt W. Evans, Argun Akcakanat, Ken Chen, Xiaofeng Zheng, Hao Zhao, Agda Karina Eterovic, Takafumi Sangai, Ashley M. Holder, Chandeshwar Sharma, Huiqin Chen, Kim Anh Do, Emily Tarco, Mihai Gagea, Katherine A. Naff, Aysegul Sahin, Asha S. Multani, Dalliah M. Black, Elizabeth A. Mittendorf, Isabelle BedrosianGordon B. Mills, Ana Maria Gonzalez-Angulo, Funda Meric-Bernstam

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Ability to generate patient-derived Breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds